VF Young Adult Leadership Expands Age Classifications To Reflect Life Stages

Young adult attendees at the 2017 International Vasculitis Symposium in Chicago.   By Ed Becker One of the challenges for the Vasculitis Foundation (VF) is addressing the needs of a portion of the patient population labeled “young adults.” It’s an imperfect name for a demographic that spans a wide age…...

Read more

Former Chapter Leader Recognized at Phoenix Conference

By Ed Becker Carole Studdard was honored March 9, 2019, for her volunteer work as a chapter leader, at the Vasculitis Patient Conference in Phoenix, Arizona. Although she now lives in Richmond, Virginia, Studdard traveled to the conference, where she was recognized with a special plaque for leading and growing…...

Read more

Longtime VF Member, Bruce Macdonald, Leaves Legacy of Service

The vasculitis community lost a special friend, Bruce Macdonald, on March 25, 2019. Macdonald was a longtime member and volunteer for the Vasculitis Foundation (formerly the Wegener’s Granulomatosis Association/Support Group). Years ago, he taught many of our members about the internet—what it was, how to use email, and look for…...

Read more

Vaccines and Vasculitis Webinar

Should I, or shouldn’t I? That is the question. Actually, this question about getting a vaccine is asked by hundreds of patients as we enter the peak flu season. Moreover, aside from the flu vaccine, patients with a compromised immune system need to know about the other immunizations for Swine…...

Read more

Study Enrolling Patients to Evaluate Efficacy and Safety of Sarilumab in Patients with Giant Cell Arteritis

Primary Objective: To evaluate the efficacy of Sarilumab in patients with giant cell arteritis (GCA) as assessed by the proportion of patients with sustained remission for Sarilumab compared to placebo, in combination with a corticosteroid (CS) tapering course. Secondary Objective: To demonstrate the efficacy of Sarilumab in patients with GCA…...

Read more